Insights & Resources

Get ahead of the curve by looking back at emerging trends in 2024 that are likely to impact health care valuation in 2025 and beyond. Download Weaver Insights now.

Weaver conducted a climate risk analysis to assess and mitigate natural disaster impacts, ensuring resilience and sustainability in our U.S. locations.

The shortage of key health care providers is impacting health care services. We explore factors driving demand and how this affects valuations.

The National Association of Manufacturers (NAM) has released its Q4 Manufacturers’ Survey. Learn more about what it means for leadership in 2025.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

Rising physician compensation and growing financial losses are putting health systems under pressure. Explore the 2024 trends and valuation insights.

Boost e-commerce success with strategic planning, profit tracking and dynamic pricing to drive growth, efficiency and long-term profitability.

Beneficial Ownership Information (BOI) reporting, a mandate of the Corporate Transparency Act (CTA), continues to be complicated.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

New York’s business interruption law introduced new stand-alone coverage opportunities, providing businesses options for tailored protection.

Weaver has developed carbon accounting processes to determine our carbon footprint across Scope 1 and Scope 2 emissions.